United States · FDA National Drug Code directory
Memantine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-652_12f3b127-625b-4c19-99f5-54f0ddc5cdc0
- Product NDC
- 65862-652
- Form
- TABLET, FILM COATED
- Composition / generic term
- Memantine Hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20151013
- Source listing expiry
- 20261231
Source-listed ingredients
- MEMANTINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (65862-652-03) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-652-10) · 65862-652-03
- 60 TABLET, FILM COATED in 1 BOTTLE (65862-652-60) · 65862-652-60
- 10 BLISTER PACK in 1 CARTON (65862-652-78) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-652-10) · 65862-652-78
- 1000 TABLET, FILM COATED in 1 BOTTLE (65862-652-99) · 65862-652-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →